ncor1 antibody Search Results


90
Bio-Techne corporation ncor1 antibody (7a7a9) - bsa free
Ncor1 Antibody (7a7a9) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncor1 antibody (7a7a9) - bsa free/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
ncor1 antibody (7a7a9) - bsa free - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Novus Biologicals mouse mono anti ncor1
Mouse Mono Anti Ncor1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse mono anti ncor1/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
mouse mono anti ncor1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti ncor1
Anti Ncor1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ncor1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti ncor1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Proteintech ncor
GPX4 suppression is regulated by a repressive complex <t>containing</t> <t>MBD2,</t> MAZ, HDAC3 and <t>NCoR.</t> (a) Peak plot showing the ATAC-seq peak at the Gpx4 locus (Chr10: 80051488–80056439) in ovarian tissues from control (Ctrl, blue) and DHEA-treated (DHEA, red) mice. Orange boxes and asterisks denote regions with increased chromatin accessibility. (b) A heatmap displays the top six transcription factors (TFs) binding to the Gpx4 promoter region in the ATAC-seq analysis, along with the mRNA expression identified by RNA-seq analysis, and the predicted TF motifs and E-values are shown on the right. (c) Schematic representation of the Gpx4 promoter region showing the MAZ binding motif relative to the transcription start site (TSS). (Below) MAZ binding footprint enrichment at the Gpx4 locus in Ctrl (blue) and DHEA-treated (red) mice. Primary ovarian granulosa cells (GCs) were treated with 50 μM DHEA for 48 h in vitro to establish the PCOS model. (d) Western blot analysis of MAZ, NCoR and HDAC3 protein expression in DHEA-treated GCs. GAPDH served as a loading control. Blots are representative of one sample per group. Quantification was presented as means ± SEM, n = 3. ∗ P < 0.05, Student's t-test. (e) Co-immunoprecipitation (Co-IP) assay. Cell lysates were immunoprecipitated (IP) with isoform-matched immunoglobulin (Ig) or antibodies (IP Ab) to MBD2, MAZ, HDAC3, or NCoR, and then immunoprecipitants were assessed for MBD2, MAZ, HDAC3, or NCoR by western blotting reciprocally (the upper panel). The non-IP lysates (Input) were assayed for GAPDH as input controls. (f) Immunofluorescence co-staining was used to determine the expression and localization of MAZ (green), NCoR (red), and HDAC3 (magenta) within GCs. (g) Quantification of protein co-localization from the magnified region in ( f ). (h) Chromatin immunoprecipitation (ChIP) assay. DHEA-treated GCs were in presence or absence of KCC-07 (KCC, 10 μM, 48 h), and the cell lysates were immunoprecipitated with isoform-matched immunoglobulin or antibodies to MBD2, MAZ, NCoR, HDAC3, or pan-acetylated lysine (Pan-Ace), respectively. The genomic DNA (Input) and the antibody-bound DNAs were PCR-amplified with primers covering the MAZ motif on Gpx4 promoter. The PCR products of representative sample per group were analyzed on 1.5 % agarose gels. Quantitative analysis was shown on the right. Data were presented as mean ± SEM, n = 4. ∗ P < 0.05, one-way ANOVA. (i) Western blot analysis. (Left) HDAC3 and GPX4 protein expression in DHEA-treated GCs in the presence or absence of the HDAC3 inhibitor RGFP966 (RGFP, 10 μM, 48 h). (Middle) MAZ and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or MAZ-targeting (si-MAZ) siRNA, followed by treatment with or without DHEA. (Right) NCoR and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or NCoR-targeting (si-NCoR) siRNA, followed by DHEA treatment. GAPDH was as a loading control. (j) Quantifications of ( i ). Data were presented as mean ± SEM, n = 3. ∗ P < 0.05, one-way ANOVA. (k) Schematic model of Gpx4 transcriptional repression. A transcriptional repressive complex orchestrated by MBD2, MAZ, HDAC3, and NCoR binds to the hypermethylated Gpx4 promoter, leading to transcriptional suppression.
Ncor, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncor/product/Proteintech
Average 93 stars, based on 1 article reviews
ncor - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Novus Biologicals ncor1
GPX4 suppression is regulated by a repressive complex <t>containing</t> <t>MBD2,</t> MAZ, HDAC3 and <t>NCoR.</t> (a) Peak plot showing the ATAC-seq peak at the Gpx4 locus (Chr10: 80051488–80056439) in ovarian tissues from control (Ctrl, blue) and DHEA-treated (DHEA, red) mice. Orange boxes and asterisks denote regions with increased chromatin accessibility. (b) A heatmap displays the top six transcription factors (TFs) binding to the Gpx4 promoter region in the ATAC-seq analysis, along with the mRNA expression identified by RNA-seq analysis, and the predicted TF motifs and E-values are shown on the right. (c) Schematic representation of the Gpx4 promoter region showing the MAZ binding motif relative to the transcription start site (TSS). (Below) MAZ binding footprint enrichment at the Gpx4 locus in Ctrl (blue) and DHEA-treated (red) mice. Primary ovarian granulosa cells (GCs) were treated with 50 μM DHEA for 48 h in vitro to establish the PCOS model. (d) Western blot analysis of MAZ, NCoR and HDAC3 protein expression in DHEA-treated GCs. GAPDH served as a loading control. Blots are representative of one sample per group. Quantification was presented as means ± SEM, n = 3. ∗ P < 0.05, Student's t-test. (e) Co-immunoprecipitation (Co-IP) assay. Cell lysates were immunoprecipitated (IP) with isoform-matched immunoglobulin (Ig) or antibodies (IP Ab) to MBD2, MAZ, HDAC3, or NCoR, and then immunoprecipitants were assessed for MBD2, MAZ, HDAC3, or NCoR by western blotting reciprocally (the upper panel). The non-IP lysates (Input) were assayed for GAPDH as input controls. (f) Immunofluorescence co-staining was used to determine the expression and localization of MAZ (green), NCoR (red), and HDAC3 (magenta) within GCs. (g) Quantification of protein co-localization from the magnified region in ( f ). (h) Chromatin immunoprecipitation (ChIP) assay. DHEA-treated GCs were in presence or absence of KCC-07 (KCC, 10 μM, 48 h), and the cell lysates were immunoprecipitated with isoform-matched immunoglobulin or antibodies to MBD2, MAZ, NCoR, HDAC3, or pan-acetylated lysine (Pan-Ace), respectively. The genomic DNA (Input) and the antibody-bound DNAs were PCR-amplified with primers covering the MAZ motif on Gpx4 promoter. The PCR products of representative sample per group were analyzed on 1.5 % agarose gels. Quantitative analysis was shown on the right. Data were presented as mean ± SEM, n = 4. ∗ P < 0.05, one-way ANOVA. (i) Western blot analysis. (Left) HDAC3 and GPX4 protein expression in DHEA-treated GCs in the presence or absence of the HDAC3 inhibitor RGFP966 (RGFP, 10 μM, 48 h). (Middle) MAZ and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or MAZ-targeting (si-MAZ) siRNA, followed by treatment with or without DHEA. (Right) NCoR and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or NCoR-targeting (si-NCoR) siRNA, followed by DHEA treatment. GAPDH was as a loading control. (j) Quantifications of ( i ). Data were presented as mean ± SEM, n = 3. ∗ P < 0.05, one-way ANOVA. (k) Schematic model of Gpx4 transcriptional repression. A transcriptional repressive complex orchestrated by MBD2, MAZ, HDAC3, and NCoR binds to the hypermethylated Gpx4 promoter, leading to transcriptional suppression.
Ncor1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncor1/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
ncor1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Novus Biologicals antibodies against ncor1 lab made
. (a) Patients carrying copy number variants (CNV) or single nucleotide variants (SNV) in <t>NCOR1</t> , NCOR2 , or HDAC3 . Genomic coordinates are shown in hg19. DDD_SNV, single nucleotide variants retrieved from Deciphering Developmental Disorders (DDD) website (United Kingdom); kb, kilobase. (b-d) Schematic representations for the deletions and point mutations affecting NCOR1 , NCOR2 , or HDAC3 , respectively, observed in patients with neurodevelopmental disorders. The locations of deletions are depicted in red, and the point mutations in pink. (e) Western blot of HEK-293 cells transfected with plasmids expressing wild-type (WT) HDAC3 with or without mutant L266S. The experiment was repeated independently once with similar results. The blot images have been cropped. (f) Fluorescence-based HDAC enzyme assay after anti-HDAC3 immunoprecipitates from cell lysates overexpressing the indicated HDAC3 proteins. Box plots center line, median; box limits, upper and lower quartiles; whiskers, minimal and maximum values. Data were analyzed by two-tailed unpaired t test. n=4 biological independent samples for each group. (g) Western blot of HEK-293 cells transfected with plasmids expressing WT HDAC3, WT NCOR1, with or without the NCOR1 deletion mutant (Del). The experiment was repeated independently once with similar results. Data were analyzed by two-tailed unpaired t test. n=3 biological independent samples for each group. The blot images have been cropped. (h) Chromatin immunoprecipitation (ChIP) with anti-HDAC3 antibodies followed by qPCR using primers targeting promoters of the indicated genes ARNTL and CDKN1A . RPLP0 serves as a negative control. Data is expressed as mean ± S.E.M. For detailed statistics results, see . * P ≤ 0.05 is set as significance.
Antibodies Against Ncor1 Lab Made, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against ncor1 lab made/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
antibodies against ncor1 lab made - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Fisher Scientific ncor1 antibody
HDAC mitotic localization results in Aurora B recruitment, phosphorylation, and decreased NCoR complex association. A, AurB co-isolates with immunopurified HDAC5 from asynchronous HEK293 cells using α-pSer278 antibody. B, AurB association with immunopurified HDAC5 S259/498A isolated from asynchronous HEK293 cells. As a positive control, disruption of 14-3-3 binding occurs in phosphomutant HDAC5 (14-3-3 ε). C, Mass spectrometry-based spectral counting reveals decreased interaction of NCoR complex members <t>(NCOR1,</t> TBL1X, and TBL1XR1) with HDAC5-EGFP after G2/M arrest (NOC) compared with an asynchronous (DMSO) control cell population, as illustrated by log2 fold change of protein abundance ratios (DMSO/NOC). 14-3-3 protein interactions are represented as the average fold change across all detected isoforms (α, ε, η, γ, σ, θ, ξ). Fold change was calculated from averaged unweighted spectrum counts from each treatment condition: NOC (n = 5) and DMSO (n = 4) following normalization to isolated HDAC5-EGFP. D, Western blot comparison of selected HDAC5 interactions (NCOR1, TBL1X, TBL1XR1, and 14-3-3ε) following isolation from G2/M-arrested (NOC) and asynchronous (DMSO) cell populations.
Ncor1 Antibody, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncor1 antibody/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
ncor1 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
FUJIFILM the anti-ncor1 antibody
HDAC mitotic localization results in Aurora B recruitment, phosphorylation, and decreased NCoR complex association. A, AurB co-isolates with immunopurified HDAC5 from asynchronous HEK293 cells using α-pSer278 antibody. B, AurB association with immunopurified HDAC5 S259/498A isolated from asynchronous HEK293 cells. As a positive control, disruption of 14-3-3 binding occurs in phosphomutant HDAC5 (14-3-3 ε). C, Mass spectrometry-based spectral counting reveals decreased interaction of NCoR complex members <t>(NCOR1,</t> TBL1X, and TBL1XR1) with HDAC5-EGFP after G2/M arrest (NOC) compared with an asynchronous (DMSO) control cell population, as illustrated by log2 fold change of protein abundance ratios (DMSO/NOC). 14-3-3 protein interactions are represented as the average fold change across all detected isoforms (α, ε, η, γ, σ, θ, ξ). Fold change was calculated from averaged unweighted spectrum counts from each treatment condition: NOC (n = 5) and DMSO (n = 4) following normalization to isolated HDAC5-EGFP. D, Western blot comparison of selected HDAC5 interactions (NCOR1, TBL1X, TBL1XR1, and 14-3-3ε) following isolation from G2/M-arrested (NOC) and asynchronous (DMSO) cell populations.
The Anti Ncor1 Antibody, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the anti-ncor1 antibody/product/FUJIFILM
Average 90 stars, based on 1 article reviews
the anti-ncor1 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Abfrontier ltd polyclonal rabbit antibody detect ncor1
(A) Heat maps displaying expression values of each gene at the indicated Zeitgeber time and Pol II-density profiles of Scd1, Cpt1a, and Cox7a1 showing diurnal expression of lipogenic, ketogenic and OxPhos genes in liver (GSE35790). (B) <t>NCoR1</t> phosphorylation by insulin treatment in HEK293T cells. Cells were transfected with Flag-tagged mouse NCoR1 (1 µg/well of 6-well plate). After 48 hours, cells were treated with insulin (100nM) for the indicated times. (C) Schematic presentation of putative mouse NCoR1 phosphorylation sites by Akt. Positions are numbered according to NCBI Reference Sequence: NP_001239242.1. RD, repression domain; SANT, the SANT-like domains; DAD, deacetylase activation domain; HID, histone interaction domain; RIDs, nuclear receptor interacting domains. AA sequences indicates (Arg-Xaa-)Arg-Xaa-Xaa-Ser/Thr motifs that have been reported to be phosphorylated by Akt/PKB in sequence 1 and 2. (D) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, each containing 1 of the 2 putative Akt phosphorylation sites of NCoR1, was analyzed by autoradiography. (E) In vitro kinase activity of Akt1 toward a synthetic GST-tagged peptide containing 1460 serine residue of NCoR1. Coomassie stain was performed to visualize the short synthetic peptides, which were used for subsequent Mass spectrometry. (F) Diagrams showing the phosphorylation of 1460 serine residue of NCoR1 by LC-MS/MS. (G) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, containing either the wild-type 1460 serine residue or mutant 1460 alanine residue of NCoR1. (H) Sequence alignment of the NCoR1 phosphorylation site in various vertebrate species. All immunoblots are representative of at least three independent experiments.
Polyclonal Rabbit Antibody Detect Ncor1, supplied by Abfrontier ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antibody detect ncor1/product/Abfrontier ltd
Average 90 stars, based on 1 article reviews
polyclonal rabbit antibody detect ncor1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Bio-Techne corporation ncor1 antibody
(A) Heat maps displaying expression values of each gene at the indicated Zeitgeber time and Pol II-density profiles of Scd1, Cpt1a, and Cox7a1 showing diurnal expression of lipogenic, ketogenic and OxPhos genes in liver (GSE35790). (B) <t>NCoR1</t> phosphorylation by insulin treatment in HEK293T cells. Cells were transfected with Flag-tagged mouse NCoR1 (1 µg/well of 6-well plate). After 48 hours, cells were treated with insulin (100nM) for the indicated times. (C) Schematic presentation of putative mouse NCoR1 phosphorylation sites by Akt. Positions are numbered according to NCBI Reference Sequence: NP_001239242.1. RD, repression domain; SANT, the SANT-like domains; DAD, deacetylase activation domain; HID, histone interaction domain; RIDs, nuclear receptor interacting domains. AA sequences indicates (Arg-Xaa-)Arg-Xaa-Xaa-Ser/Thr motifs that have been reported to be phosphorylated by Akt/PKB in sequence 1 and 2. (D) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, each containing 1 of the 2 putative Akt phosphorylation sites of NCoR1, was analyzed by autoradiography. (E) In vitro kinase activity of Akt1 toward a synthetic GST-tagged peptide containing 1460 serine residue of NCoR1. Coomassie stain was performed to visualize the short synthetic peptides, which were used for subsequent Mass spectrometry. (F) Diagrams showing the phosphorylation of 1460 serine residue of NCoR1 by LC-MS/MS. (G) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, containing either the wild-type 1460 serine residue or mutant 1460 alanine residue of NCoR1. (H) Sequence alignment of the NCoR1 phosphorylation site in various vertebrate species. All immunoblots are representative of at least three independent experiments.
Ncor1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncor1 antibody/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
ncor1 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

N/A
Nuclear co-repressor 2 (N-CoR2) gene (NCOR2, previously called silencing mediator for retinoid and thyroid hormone receptor SMRT) is recruited to nuclear and non-nuclear receptors in a large repressing complex containing also N-CoR1, mSin3 and HDACs.
  Buy from Supplier

N/A
NCOR1 antibody was raised in Rabbit using Human NCOR1 as the immunogen. Rabbit polyclonal NCOR1 antibody.
  Buy from Supplier

Image Search Results


GPX4 suppression is regulated by a repressive complex containing MBD2, MAZ, HDAC3 and NCoR. (a) Peak plot showing the ATAC-seq peak at the Gpx4 locus (Chr10: 80051488–80056439) in ovarian tissues from control (Ctrl, blue) and DHEA-treated (DHEA, red) mice. Orange boxes and asterisks denote regions with increased chromatin accessibility. (b) A heatmap displays the top six transcription factors (TFs) binding to the Gpx4 promoter region in the ATAC-seq analysis, along with the mRNA expression identified by RNA-seq analysis, and the predicted TF motifs and E-values are shown on the right. (c) Schematic representation of the Gpx4 promoter region showing the MAZ binding motif relative to the transcription start site (TSS). (Below) MAZ binding footprint enrichment at the Gpx4 locus in Ctrl (blue) and DHEA-treated (red) mice. Primary ovarian granulosa cells (GCs) were treated with 50 μM DHEA for 48 h in vitro to establish the PCOS model. (d) Western blot analysis of MAZ, NCoR and HDAC3 protein expression in DHEA-treated GCs. GAPDH served as a loading control. Blots are representative of one sample per group. Quantification was presented as means ± SEM, n = 3. ∗ P < 0.05, Student's t-test. (e) Co-immunoprecipitation (Co-IP) assay. Cell lysates were immunoprecipitated (IP) with isoform-matched immunoglobulin (Ig) or antibodies (IP Ab) to MBD2, MAZ, HDAC3, or NCoR, and then immunoprecipitants were assessed for MBD2, MAZ, HDAC3, or NCoR by western blotting reciprocally (the upper panel). The non-IP lysates (Input) were assayed for GAPDH as input controls. (f) Immunofluorescence co-staining was used to determine the expression and localization of MAZ (green), NCoR (red), and HDAC3 (magenta) within GCs. (g) Quantification of protein co-localization from the magnified region in ( f ). (h) Chromatin immunoprecipitation (ChIP) assay. DHEA-treated GCs were in presence or absence of KCC-07 (KCC, 10 μM, 48 h), and the cell lysates were immunoprecipitated with isoform-matched immunoglobulin or antibodies to MBD2, MAZ, NCoR, HDAC3, or pan-acetylated lysine (Pan-Ace), respectively. The genomic DNA (Input) and the antibody-bound DNAs were PCR-amplified with primers covering the MAZ motif on Gpx4 promoter. The PCR products of representative sample per group were analyzed on 1.5 % agarose gels. Quantitative analysis was shown on the right. Data were presented as mean ± SEM, n = 4. ∗ P < 0.05, one-way ANOVA. (i) Western blot analysis. (Left) HDAC3 and GPX4 protein expression in DHEA-treated GCs in the presence or absence of the HDAC3 inhibitor RGFP966 (RGFP, 10 μM, 48 h). (Middle) MAZ and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or MAZ-targeting (si-MAZ) siRNA, followed by treatment with or without DHEA. (Right) NCoR and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or NCoR-targeting (si-NCoR) siRNA, followed by DHEA treatment. GAPDH was as a loading control. (j) Quantifications of ( i ). Data were presented as mean ± SEM, n = 3. ∗ P < 0.05, one-way ANOVA. (k) Schematic model of Gpx4 transcriptional repression. A transcriptional repressive complex orchestrated by MBD2, MAZ, HDAC3, and NCoR binds to the hypermethylated Gpx4 promoter, leading to transcriptional suppression.

Journal: Redox Biology

Article Title: Methylation reader MBD2-mediated GPX4 transcriptional repression drives ovarian granulosa cell ferroptosis in PCOS

doi: 10.1016/j.redox.2026.104034

Figure Lengend Snippet: GPX4 suppression is regulated by a repressive complex containing MBD2, MAZ, HDAC3 and NCoR. (a) Peak plot showing the ATAC-seq peak at the Gpx4 locus (Chr10: 80051488–80056439) in ovarian tissues from control (Ctrl, blue) and DHEA-treated (DHEA, red) mice. Orange boxes and asterisks denote regions with increased chromatin accessibility. (b) A heatmap displays the top six transcription factors (TFs) binding to the Gpx4 promoter region in the ATAC-seq analysis, along with the mRNA expression identified by RNA-seq analysis, and the predicted TF motifs and E-values are shown on the right. (c) Schematic representation of the Gpx4 promoter region showing the MAZ binding motif relative to the transcription start site (TSS). (Below) MAZ binding footprint enrichment at the Gpx4 locus in Ctrl (blue) and DHEA-treated (red) mice. Primary ovarian granulosa cells (GCs) were treated with 50 μM DHEA for 48 h in vitro to establish the PCOS model. (d) Western blot analysis of MAZ, NCoR and HDAC3 protein expression in DHEA-treated GCs. GAPDH served as a loading control. Blots are representative of one sample per group. Quantification was presented as means ± SEM, n = 3. ∗ P < 0.05, Student's t-test. (e) Co-immunoprecipitation (Co-IP) assay. Cell lysates were immunoprecipitated (IP) with isoform-matched immunoglobulin (Ig) or antibodies (IP Ab) to MBD2, MAZ, HDAC3, or NCoR, and then immunoprecipitants were assessed for MBD2, MAZ, HDAC3, or NCoR by western blotting reciprocally (the upper panel). The non-IP lysates (Input) were assayed for GAPDH as input controls. (f) Immunofluorescence co-staining was used to determine the expression and localization of MAZ (green), NCoR (red), and HDAC3 (magenta) within GCs. (g) Quantification of protein co-localization from the magnified region in ( f ). (h) Chromatin immunoprecipitation (ChIP) assay. DHEA-treated GCs were in presence or absence of KCC-07 (KCC, 10 μM, 48 h), and the cell lysates were immunoprecipitated with isoform-matched immunoglobulin or antibodies to MBD2, MAZ, NCoR, HDAC3, or pan-acetylated lysine (Pan-Ace), respectively. The genomic DNA (Input) and the antibody-bound DNAs were PCR-amplified with primers covering the MAZ motif on Gpx4 promoter. The PCR products of representative sample per group were analyzed on 1.5 % agarose gels. Quantitative analysis was shown on the right. Data were presented as mean ± SEM, n = 4. ∗ P < 0.05, one-way ANOVA. (i) Western blot analysis. (Left) HDAC3 and GPX4 protein expression in DHEA-treated GCs in the presence or absence of the HDAC3 inhibitor RGFP966 (RGFP, 10 μM, 48 h). (Middle) MAZ and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or MAZ-targeting (si-MAZ) siRNA, followed by treatment with or without DHEA. (Right) NCoR and GPX4 protein expression in GCs transfected with negative- (si-Ctrl) or NCoR-targeting (si-NCoR) siRNA, followed by DHEA treatment. GAPDH was as a loading control. (j) Quantifications of ( i ). Data were presented as mean ± SEM, n = 3. ∗ P < 0.05, one-way ANOVA. (k) Schematic model of Gpx4 transcriptional repression. A transcriptional repressive complex orchestrated by MBD2, MAZ, HDAC3, and NCoR binds to the hypermethylated Gpx4 promoter, leading to transcriptional suppression.

Article Snippet: The lysates of ovaries were immunoprecipitated with antibodies to MBD2 (ab188474, Abcam, UK), MAZ (21068-1-AP, Proteintech, USA), HDAC3 (A19537, ABclonal, China), NCoR (20018-1-AP, Proteintech, USA), or an isotype-matched immunoglobulin (Ig) followed by Protein A/G Magnetic Beads (PB101, Vazyme, China), and then immunoprecipitants were assayed by Western blot with antibodies to MBD2, MAZ, HDAC3 or NCoR, respectively.

Techniques: Control, Binding Assay, Expressing, RNA Sequencing, In Vitro, Western Blot, Co-Immunoprecipitation Assay, Immunoprecipitation, Immunofluorescence, Staining, Chromatin Immunoprecipitation, Amplification, Transfection

Granulosa GPX4 deletion blocks the anti-ferroptotic and ovary-protective effects of MBD2 inhibition in PCOS mice. Gpx4 fl/fl and Gpx4 GC−/− mice were grouped into oil vehicle control (Ctrl), DHEA (60 mg/kg, 21 days)-treated (DHEA), and DHEA-treated with KCC-07 (KCC, 10 mg/kg) treatment (KCC/DHEA) mice ( n = 6). (a) Representative photomicrographs of ovarian sections. Ovarian sections were stained with hematoxylin-eosin (HE; upper panels), Masson trichrome (middle panels), and TUNEL assay (lower panels). Asterisks indicate corpora lutea; black arrows indicate preantral follicles; yellow arrows indicate collagen deposits; white arrows indicate TUNEL-positive cells. (b) Quantification of ( a ). Box-and-whisker plots with data points ( n = 6). ∗ P < 0.05, two-way ANOVA. (c) Western blot analysis of GPX4, 4-HNE, Collagen I (Col1α) and α-SMA protein expression in ovarian tissues. GAPDH served as a loading control. Blots are representative of two samples per group. (d) Quantification of ( c ). Data were presented as mean ± SEM, n = 6. ∗ P < 0.05, two -way ANOVA. (e) A schematic diagram of sequential MBD2 elevation, formation of a transcriptional repressive complex with MAZ, NCoR and HDAC3, binding to the DNMT-hypermethylated Gpx4 promoter, suppression of Gpx4 transcription, and granulosa cell ferroptosis that promotes polycystic ovary syndrome (PCOS) (dashed lines). Conversely, MBD2 inhibition with KCC-07 blocks GPX4 suppression and ferroptotic PCOS (solid lines).

Journal: Redox Biology

Article Title: Methylation reader MBD2-mediated GPX4 transcriptional repression drives ovarian granulosa cell ferroptosis in PCOS

doi: 10.1016/j.redox.2026.104034

Figure Lengend Snippet: Granulosa GPX4 deletion blocks the anti-ferroptotic and ovary-protective effects of MBD2 inhibition in PCOS mice. Gpx4 fl/fl and Gpx4 GC−/− mice were grouped into oil vehicle control (Ctrl), DHEA (60 mg/kg, 21 days)-treated (DHEA), and DHEA-treated with KCC-07 (KCC, 10 mg/kg) treatment (KCC/DHEA) mice ( n = 6). (a) Representative photomicrographs of ovarian sections. Ovarian sections were stained with hematoxylin-eosin (HE; upper panels), Masson trichrome (middle panels), and TUNEL assay (lower panels). Asterisks indicate corpora lutea; black arrows indicate preantral follicles; yellow arrows indicate collagen deposits; white arrows indicate TUNEL-positive cells. (b) Quantification of ( a ). Box-and-whisker plots with data points ( n = 6). ∗ P < 0.05, two-way ANOVA. (c) Western blot analysis of GPX4, 4-HNE, Collagen I (Col1α) and α-SMA protein expression in ovarian tissues. GAPDH served as a loading control. Blots are representative of two samples per group. (d) Quantification of ( c ). Data were presented as mean ± SEM, n = 6. ∗ P < 0.05, two -way ANOVA. (e) A schematic diagram of sequential MBD2 elevation, formation of a transcriptional repressive complex with MAZ, NCoR and HDAC3, binding to the DNMT-hypermethylated Gpx4 promoter, suppression of Gpx4 transcription, and granulosa cell ferroptosis that promotes polycystic ovary syndrome (PCOS) (dashed lines). Conversely, MBD2 inhibition with KCC-07 blocks GPX4 suppression and ferroptotic PCOS (solid lines).

Article Snippet: The lysates of ovaries were immunoprecipitated with antibodies to MBD2 (ab188474, Abcam, UK), MAZ (21068-1-AP, Proteintech, USA), HDAC3 (A19537, ABclonal, China), NCoR (20018-1-AP, Proteintech, USA), or an isotype-matched immunoglobulin (Ig) followed by Protein A/G Magnetic Beads (PB101, Vazyme, China), and then immunoprecipitants were assayed by Western blot with antibodies to MBD2, MAZ, HDAC3 or NCoR, respectively.

Techniques: Inhibition, Control, Staining, TUNEL Assay, Whisker Assay, Western Blot, Expressing, Binding Assay

. (a) Patients carrying copy number variants (CNV) or single nucleotide variants (SNV) in NCOR1 , NCOR2 , or HDAC3 . Genomic coordinates are shown in hg19. DDD_SNV, single nucleotide variants retrieved from Deciphering Developmental Disorders (DDD) website (United Kingdom); kb, kilobase. (b-d) Schematic representations for the deletions and point mutations affecting NCOR1 , NCOR2 , or HDAC3 , respectively, observed in patients with neurodevelopmental disorders. The locations of deletions are depicted in red, and the point mutations in pink. (e) Western blot of HEK-293 cells transfected with plasmids expressing wild-type (WT) HDAC3 with or without mutant L266S. The experiment was repeated independently once with similar results. The blot images have been cropped. (f) Fluorescence-based HDAC enzyme assay after anti-HDAC3 immunoprecipitates from cell lysates overexpressing the indicated HDAC3 proteins. Box plots center line, median; box limits, upper and lower quartiles; whiskers, minimal and maximum values. Data were analyzed by two-tailed unpaired t test. n=4 biological independent samples for each group. (g) Western blot of HEK-293 cells transfected with plasmids expressing WT HDAC3, WT NCOR1, with or without the NCOR1 deletion mutant (Del). The experiment was repeated independently once with similar results. Data were analyzed by two-tailed unpaired t test. n=3 biological independent samples for each group. The blot images have been cropped. (h) Chromatin immunoprecipitation (ChIP) with anti-HDAC3 antibodies followed by qPCR using primers targeting promoters of the indicated genes ARNTL and CDKN1A . RPLP0 serves as a negative control. Data is expressed as mean ± S.E.M. For detailed statistics results, see . * P ≤ 0.05 is set as significance.

Journal: Nature neuroscience

Article Title: NCOR1/2 loss of function impairs memory through a novel GABAergic hypothalamus–CA3 projection

doi: 10.1038/s41593-018-0311-1

Figure Lengend Snippet: . (a) Patients carrying copy number variants (CNV) or single nucleotide variants (SNV) in NCOR1 , NCOR2 , or HDAC3 . Genomic coordinates are shown in hg19. DDD_SNV, single nucleotide variants retrieved from Deciphering Developmental Disorders (DDD) website (United Kingdom); kb, kilobase. (b-d) Schematic representations for the deletions and point mutations affecting NCOR1 , NCOR2 , or HDAC3 , respectively, observed in patients with neurodevelopmental disorders. The locations of deletions are depicted in red, and the point mutations in pink. (e) Western blot of HEK-293 cells transfected with plasmids expressing wild-type (WT) HDAC3 with or without mutant L266S. The experiment was repeated independently once with similar results. The blot images have been cropped. (f) Fluorescence-based HDAC enzyme assay after anti-HDAC3 immunoprecipitates from cell lysates overexpressing the indicated HDAC3 proteins. Box plots center line, median; box limits, upper and lower quartiles; whiskers, minimal and maximum values. Data were analyzed by two-tailed unpaired t test. n=4 biological independent samples for each group. (g) Western blot of HEK-293 cells transfected with plasmids expressing WT HDAC3, WT NCOR1, with or without the NCOR1 deletion mutant (Del). The experiment was repeated independently once with similar results. Data were analyzed by two-tailed unpaired t test. n=3 biological independent samples for each group. The blot images have been cropped. (h) Chromatin immunoprecipitation (ChIP) with anti-HDAC3 antibodies followed by qPCR using primers targeting promoters of the indicated genes ARNTL and CDKN1A . RPLP0 serves as a negative control. Data is expressed as mean ± S.E.M. For detailed statistics results, see . * P ≤ 0.05 is set as significance.

Article Snippet: For western blot, immunoprecipitates and total tissue lysates were resolved by Tris-glycine SDS-PAGE, transferred to PVDF membranes, and blotted with antibodies against NCOR1 (lab-made) , TBLR1 (IMGENEX, IMG591), and HDAC3 (Abcam 7030).

Techniques: Western Blot, Transfection, Expressing, Mutagenesis, Fluorescence, Enzymatic Assay, Two Tailed Test, Chromatin Immunoprecipitation, Negative Control

HDAC mitotic localization results in Aurora B recruitment, phosphorylation, and decreased NCoR complex association. A, AurB co-isolates with immunopurified HDAC5 from asynchronous HEK293 cells using α-pSer278 antibody. B, AurB association with immunopurified HDAC5 S259/498A isolated from asynchronous HEK293 cells. As a positive control, disruption of 14-3-3 binding occurs in phosphomutant HDAC5 (14-3-3 ε). C, Mass spectrometry-based spectral counting reveals decreased interaction of NCoR complex members (NCOR1, TBL1X, and TBL1XR1) with HDAC5-EGFP after G2/M arrest (NOC) compared with an asynchronous (DMSO) control cell population, as illustrated by log2 fold change of protein abundance ratios (DMSO/NOC). 14-3-3 protein interactions are represented as the average fold change across all detected isoforms (α, ε, η, γ, σ, θ, ξ). Fold change was calculated from averaged unweighted spectrum counts from each treatment condition: NOC (n = 5) and DMSO (n = 4) following normalization to isolated HDAC5-EGFP. D, Western blot comparison of selected HDAC5 interactions (NCOR1, TBL1X, TBL1XR1, and 14-3-3ε) following isolation from G2/M-arrested (NOC) and asynchronous (DMSO) cell populations.

Journal: Molecular & Cellular Proteomics : MCP

Article Title: Aurora B-dependent Regulation of Class IIa Histone Deacetylases by Mitotic Nuclear Localization Signal Phosphorylation *

doi: 10.1074/mcp.M112.021030

Figure Lengend Snippet: HDAC mitotic localization results in Aurora B recruitment, phosphorylation, and decreased NCoR complex association. A, AurB co-isolates with immunopurified HDAC5 from asynchronous HEK293 cells using α-pSer278 antibody. B, AurB association with immunopurified HDAC5 S259/498A isolated from asynchronous HEK293 cells. As a positive control, disruption of 14-3-3 binding occurs in phosphomutant HDAC5 (14-3-3 ε). C, Mass spectrometry-based spectral counting reveals decreased interaction of NCoR complex members (NCOR1, TBL1X, and TBL1XR1) with HDAC5-EGFP after G2/M arrest (NOC) compared with an asynchronous (DMSO) control cell population, as illustrated by log2 fold change of protein abundance ratios (DMSO/NOC). 14-3-3 protein interactions are represented as the average fold change across all detected isoforms (α, ε, η, γ, σ, θ, ξ). Fold change was calculated from averaged unweighted spectrum counts from each treatment condition: NOC (n = 5) and DMSO (n = 4) following normalization to isolated HDAC5-EGFP. D, Western blot comparison of selected HDAC5 interactions (NCOR1, TBL1X, TBL1XR1, and 14-3-3ε) following isolation from G2/M-arrested (NOC) and asynchronous (DMSO) cell populations.

Article Snippet: Antibodies The antibodies used in these experiments for immunoaffinity purifications, Western blotting, and immunofluorescence studies were an in-house developed rabbit polyclonal antibody against GFP, as described ( 24 ), monoclonal anti-GFP (Roche), MAb414 (Covance, gift from J. Glavy, Stevens Institute), Aurora B (Abcam, Cambridge, MA), GAPDH (Abcam), 14-3-3ε (T-16, Santa Cruz, CA), H3pS10 (Millipore), Tubulin (Roche), NCOR1 (Fisher Scientific), TBL1X (Santa Cruz Biotechnology, Santa Cruz, CA), TBL1XR1 (Santa Cruz Biotechnology), and HDAC3 (Santa Cruz Biotechnology).

Techniques: Phospho-proteomics, Isolation, Positive Control, Disruption, Binding Assay, Mass Spectrometry, Control, Quantitative Proteomics, Western Blot, Comparison

(A) Heat maps displaying expression values of each gene at the indicated Zeitgeber time and Pol II-density profiles of Scd1, Cpt1a, and Cox7a1 showing diurnal expression of lipogenic, ketogenic and OxPhos genes in liver (GSE35790). (B) NCoR1 phosphorylation by insulin treatment in HEK293T cells. Cells were transfected with Flag-tagged mouse NCoR1 (1 µg/well of 6-well plate). After 48 hours, cells were treated with insulin (100nM) for the indicated times. (C) Schematic presentation of putative mouse NCoR1 phosphorylation sites by Akt. Positions are numbered according to NCBI Reference Sequence: NP_001239242.1. RD, repression domain; SANT, the SANT-like domains; DAD, deacetylase activation domain; HID, histone interaction domain; RIDs, nuclear receptor interacting domains. AA sequences indicates (Arg-Xaa-)Arg-Xaa-Xaa-Ser/Thr motifs that have been reported to be phosphorylated by Akt/PKB in sequence 1 and 2. (D) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, each containing 1 of the 2 putative Akt phosphorylation sites of NCoR1, was analyzed by autoradiography. (E) In vitro kinase activity of Akt1 toward a synthetic GST-tagged peptide containing 1460 serine residue of NCoR1. Coomassie stain was performed to visualize the short synthetic peptides, which were used for subsequent Mass spectrometry. (F) Diagrams showing the phosphorylation of 1460 serine residue of NCoR1 by LC-MS/MS. (G) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, containing either the wild-type 1460 serine residue or mutant 1460 alanine residue of NCoR1. (H) Sequence alignment of the NCoR1 phosphorylation site in various vertebrate species. All immunoblots are representative of at least three independent experiments.

Journal: Hepatology (Baltimore, Md.)

Article Title: Phosphorylation of the Nuclear Receptor Co-repressor 1 by Protein Kinase B (PKB/Akt) Switches its Co-repressor Targets in the Liver

doi: 10.1002/hep.27907

Figure Lengend Snippet: (A) Heat maps displaying expression values of each gene at the indicated Zeitgeber time and Pol II-density profiles of Scd1, Cpt1a, and Cox7a1 showing diurnal expression of lipogenic, ketogenic and OxPhos genes in liver (GSE35790). (B) NCoR1 phosphorylation by insulin treatment in HEK293T cells. Cells were transfected with Flag-tagged mouse NCoR1 (1 µg/well of 6-well plate). After 48 hours, cells were treated with insulin (100nM) for the indicated times. (C) Schematic presentation of putative mouse NCoR1 phosphorylation sites by Akt. Positions are numbered according to NCBI Reference Sequence: NP_001239242.1. RD, repression domain; SANT, the SANT-like domains; DAD, deacetylase activation domain; HID, histone interaction domain; RIDs, nuclear receptor interacting domains. AA sequences indicates (Arg-Xaa-)Arg-Xaa-Xaa-Ser/Thr motifs that have been reported to be phosphorylated by Akt/PKB in sequence 1 and 2. (D) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, each containing 1 of the 2 putative Akt phosphorylation sites of NCoR1, was analyzed by autoradiography. (E) In vitro kinase activity of Akt1 toward a synthetic GST-tagged peptide containing 1460 serine residue of NCoR1. Coomassie stain was performed to visualize the short synthetic peptides, which were used for subsequent Mass spectrometry. (F) Diagrams showing the phosphorylation of 1460 serine residue of NCoR1 by LC-MS/MS. (G) In vitro kinase activity of Akt1 toward two short synthetic GST-tagged peptides, containing either the wild-type 1460 serine residue or mutant 1460 alanine residue of NCoR1. (H) Sequence alignment of the NCoR1 phosphorylation site in various vertebrate species. All immunoblots are representative of at least three independent experiments.

Article Snippet: But, polyclonal rabbit antibody to detect NCoR1, which is specifically phosphorylated on 1460 serine (Anti-pS1460 NCoR1 Ab) was generated in Young In Frontier Co., Ltd (Seoul, South Korea).

Techniques: Expressing, Transfection, Sequencing, Histone Deacetylase Assay, Activation Assay, In Vitro, Activity Assay, Autoradiography, Staining, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy, Mutagenesis, Western Blot

(A) Co-immunoprecipitation assay using wild-type Flag-NCoR1, Flag-S1460E NCoR1 (SE), Flag-S1460A NCoR1 (SA) and HA-LXRα in HEK293T cells. Cells were transfected with indicated plasmids (1 µg/well per 6-well plate). After 48 hours, cell lysates were immunoprecipitated with anti-Flag antibody. (B and C) Similar co-immunoprecipitation assays using the same NCoR1 constructs as in (A) and HA-PPARα (B) and HA-ERRα (C). (D-F) NCoR1 recruitment to the LXRE (D), PPRE (E) and ERRE (F) sites of the mouse Srebp1c, Cpt1a and Sdhb promoters determined by ChIP in AML12 cells and quantitative RT-PCR (qRT-PCR) analysis of the mRNA levels of Srebp1c (D), Cpt1a (E) and Sdhb (F) according to the sequence composition of NCoR1 phosphorylation site (each group, n>5). mRNA levels were analyzed in AML12 cells transfected with indicated NCoR1 plasmids (each group, n>7) (G) Co-immunoprecipitation assay using wild-type Flag-NCoR1, Flag-S1460A NCoR1 (SA) and HA-LXRα (1 µg/well per 6-well plate) in AML12 cells with or without GW3965 (1 µM) as indicated. (H) NCoR1 recruitment to the LXRE of the mouse Srebp1c, promoters determined by ChIP and quantitative RT-PCR (qRT-PCR) analysis of the mRNA levels of Srebp1c in AML12 cells according to the sequence composition of the S1460 NCoR1 phosphorylation site in the absence or presence of insulin (100 nM) for 6 h with or without LY294002 (30 µM) given 30 min before insulin treatment (each group, n>5). (I) qRT-PCR analysis to evaluate mRNA levels of Srebp1c and Fasn in primary hepatocytes from NCoR1L2/L2 mice infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium with or without insulin treatment (100nM) for 6 h. All immunoblots are representative of at least three independent experiments. Data are mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Hepatology (Baltimore, Md.)

Article Title: Phosphorylation of the Nuclear Receptor Co-repressor 1 by Protein Kinase B (PKB/Akt) Switches its Co-repressor Targets in the Liver

doi: 10.1002/hep.27907

Figure Lengend Snippet: (A) Co-immunoprecipitation assay using wild-type Flag-NCoR1, Flag-S1460E NCoR1 (SE), Flag-S1460A NCoR1 (SA) and HA-LXRα in HEK293T cells. Cells were transfected with indicated plasmids (1 µg/well per 6-well plate). After 48 hours, cell lysates were immunoprecipitated with anti-Flag antibody. (B and C) Similar co-immunoprecipitation assays using the same NCoR1 constructs as in (A) and HA-PPARα (B) and HA-ERRα (C). (D-F) NCoR1 recruitment to the LXRE (D), PPRE (E) and ERRE (F) sites of the mouse Srebp1c, Cpt1a and Sdhb promoters determined by ChIP in AML12 cells and quantitative RT-PCR (qRT-PCR) analysis of the mRNA levels of Srebp1c (D), Cpt1a (E) and Sdhb (F) according to the sequence composition of NCoR1 phosphorylation site (each group, n>5). mRNA levels were analyzed in AML12 cells transfected with indicated NCoR1 plasmids (each group, n>7) (G) Co-immunoprecipitation assay using wild-type Flag-NCoR1, Flag-S1460A NCoR1 (SA) and HA-LXRα (1 µg/well per 6-well plate) in AML12 cells with or without GW3965 (1 µM) as indicated. (H) NCoR1 recruitment to the LXRE of the mouse Srebp1c, promoters determined by ChIP and quantitative RT-PCR (qRT-PCR) analysis of the mRNA levels of Srebp1c in AML12 cells according to the sequence composition of the S1460 NCoR1 phosphorylation site in the absence or presence of insulin (100 nM) for 6 h with or without LY294002 (30 µM) given 30 min before insulin treatment (each group, n>5). (I) qRT-PCR analysis to evaluate mRNA levels of Srebp1c and Fasn in primary hepatocytes from NCoR1L2/L2 mice infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium with or without insulin treatment (100nM) for 6 h. All immunoblots are representative of at least three independent experiments. Data are mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: But, polyclonal rabbit antibody to detect NCoR1, which is specifically phosphorylated on 1460 serine (Anti-pS1460 NCoR1 Ab) was generated in Young In Frontier Co., Ltd (Seoul, South Korea).

Techniques: Co-Immunoprecipitation Assay, Transfection, Immunoprecipitation, Construct, Quantitative RT-PCR, Sequencing, Infection, Western Blot

Acute NCoR1 deletion results in induction of lipogenic and OxPhos genes. (A) qRT-PCR analysis to evaluate mRNA levels of Ndufb5, Sdhb, Uqcrfs1, Cox5a, Atp5g1 and Ncor1 in NCoR1L2/L2 MEF cells infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium. (B) Western blot analysis showing Atp5a, Uqcrc2, Mtco1, Sdhb and Ndufb8 levels in NCoR1L2/L2 MEFs infected during 72-hr with either an Ad-LacZ or Ad-Cre adenovirus. (C) BN-PAGE of OXPHOS complexes in mitochondria isolated from NCoR1L2/L2 MEFs infected with either an Ad-LacZ or Ad-Cre adenovirus. (D) Oxygen consumption rate (OCR) was measured in NCoR1L2/L2 MEFs infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium (n=6/group). Data are mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (E) qRT-PCR analysis to evaluate mRNA levels of Ndufb5, Sdhb, Uqcrfs1, Cox5a, Atp5g1, Me1, G6pdx, Scd1, Gpam, Fasn, Plin2 and Ncor1 in primary hepatocytes from NCoR1L2/L2 mice infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium.

Journal: Hepatology (Baltimore, Md.)

Article Title: Phosphorylation of the Nuclear Receptor Co-repressor 1 by Protein Kinase B (PKB/Akt) Switches its Co-repressor Targets in the Liver

doi: 10.1002/hep.27907

Figure Lengend Snippet: Acute NCoR1 deletion results in induction of lipogenic and OxPhos genes. (A) qRT-PCR analysis to evaluate mRNA levels of Ndufb5, Sdhb, Uqcrfs1, Cox5a, Atp5g1 and Ncor1 in NCoR1L2/L2 MEF cells infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium. (B) Western blot analysis showing Atp5a, Uqcrc2, Mtco1, Sdhb and Ndufb8 levels in NCoR1L2/L2 MEFs infected during 72-hr with either an Ad-LacZ or Ad-Cre adenovirus. (C) BN-PAGE of OXPHOS complexes in mitochondria isolated from NCoR1L2/L2 MEFs infected with either an Ad-LacZ or Ad-Cre adenovirus. (D) Oxygen consumption rate (OCR) was measured in NCoR1L2/L2 MEFs infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium (n=6/group). Data are mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (E) qRT-PCR analysis to evaluate mRNA levels of Ndufb5, Sdhb, Uqcrfs1, Cox5a, Atp5g1, Me1, G6pdx, Scd1, Gpam, Fasn, Plin2 and Ncor1 in primary hepatocytes from NCoR1L2/L2 mice infected with either an Ad-LacZ or Ad-Cre adenovirus grown in high glucose (25 mM) medium.

Article Snippet: But, polyclonal rabbit antibody to detect NCoR1, which is specifically phosphorylated on 1460 serine (Anti-pS1460 NCoR1 Ab) was generated in Young In Frontier Co., Ltd (Seoul, South Korea).

Techniques: Quantitative RT-PCR, Infection, Western Blot, Isolation

(A) mRNA levels of Me1, Fasn, Elovl6, Srebp1, Srebp2, Acox1, mCad, Cpt1a, Esrra, Ndufb5 and Sdhb were evaluated by qRT-PCR in livers of NCoR1hep+/+ and NCoR1hep−/− mice fasted for 24-hr (n > 7/group). All data shown as mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (B) BN-PAGE of OXPHOS complexes in mitochondria isolated from liver of 25-wk old male NCoR1hep+/+ and NCoR1hep−/− mice either fed or fasted for 24-hr. Upper panel is a representative result developed by chromogen-based detection technique to visualize supercomplexes (SC), complex I, V and III. The lower panel shows HRP-based detection to evaluate complex II amount. (C) Western blot analysis indicating that insulin increases pS1460 NCoR1 in livers from 25-wk old NCoR1hep+/+ and NCoR1hep−/− male chow fed mice. Animals were injected with either PBS or insulin (0.5 U/kg body weight) at 10 min before sacrificing. (D) Western blot analysis showing that PI3K inhibition attenuates the insulin-induced increases of pS1460 NCoR1 in livers from 25-wk old 4-hr fasted C57BL/6J male chow fed mice. After 4 hrs of fasting, animals were injected with either PBS or insulin (0.5 U/kg body weight) for 10 min or 30 min with or without LY294002 (40 mg/kg) which was given 60 min before sacrifice. (E) pS1460 NCoR1 levels in livers from 25-wk old C57BL/6J male mice fed with either chow or high fat diet for 12-wk. (F) pS1460 NCoR1 levels in livers from 12-wk old male db/db mice. Animals in (E) and (F) were fasted for 4-hr. The experimental protocol is similar to that used in (C). All immunoblots are representative of at least three independent experiments. (G) Working model, summarizing how NCoR1 may control the fasting-feeding transitions in liver in a phosphorylation dependent manner.

Journal: Hepatology (Baltimore, Md.)

Article Title: Phosphorylation of the Nuclear Receptor Co-repressor 1 by Protein Kinase B (PKB/Akt) Switches its Co-repressor Targets in the Liver

doi: 10.1002/hep.27907

Figure Lengend Snippet: (A) mRNA levels of Me1, Fasn, Elovl6, Srebp1, Srebp2, Acox1, mCad, Cpt1a, Esrra, Ndufb5 and Sdhb were evaluated by qRT-PCR in livers of NCoR1hep+/+ and NCoR1hep−/− mice fasted for 24-hr (n > 7/group). All data shown as mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (B) BN-PAGE of OXPHOS complexes in mitochondria isolated from liver of 25-wk old male NCoR1hep+/+ and NCoR1hep−/− mice either fed or fasted for 24-hr. Upper panel is a representative result developed by chromogen-based detection technique to visualize supercomplexes (SC), complex I, V and III. The lower panel shows HRP-based detection to evaluate complex II amount. (C) Western blot analysis indicating that insulin increases pS1460 NCoR1 in livers from 25-wk old NCoR1hep+/+ and NCoR1hep−/− male chow fed mice. Animals were injected with either PBS or insulin (0.5 U/kg body weight) at 10 min before sacrificing. (D) Western blot analysis showing that PI3K inhibition attenuates the insulin-induced increases of pS1460 NCoR1 in livers from 25-wk old 4-hr fasted C57BL/6J male chow fed mice. After 4 hrs of fasting, animals were injected with either PBS or insulin (0.5 U/kg body weight) for 10 min or 30 min with or without LY294002 (40 mg/kg) which was given 60 min before sacrifice. (E) pS1460 NCoR1 levels in livers from 25-wk old C57BL/6J male mice fed with either chow or high fat diet for 12-wk. (F) pS1460 NCoR1 levels in livers from 12-wk old male db/db mice. Animals in (E) and (F) were fasted for 4-hr. The experimental protocol is similar to that used in (C). All immunoblots are representative of at least three independent experiments. (G) Working model, summarizing how NCoR1 may control the fasting-feeding transitions in liver in a phosphorylation dependent manner.

Article Snippet: But, polyclonal rabbit antibody to detect NCoR1, which is specifically phosphorylated on 1460 serine (Anti-pS1460 NCoR1 Ab) was generated in Young In Frontier Co., Ltd (Seoul, South Korea).

Techniques: Quantitative RT-PCR, Isolation, Western Blot, Injection, Inhibition